ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 198

$679K Total Retail Price of All Prescriptions

Rank: 34 out of 198

517 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,269 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 720 646 1 1
SIMVASTATIN 576 507 2 2
HYDROCODONE-ACETAMINOPHEN 525 452 S3 3 8
AMLODIPINE BESYLATE 464 437 4 4
ATENOLOL 389 365 5 17
OMEPRAZOLE 357 296 6 3
LOSARTAN POTASSIUM 354 335 7 18
FUROSEMIDE 326 296 8 5
WARFARIN SODIUM 301 298 9 7
LISINOPRIL 290 233 10 6
ATORVASTATIN CALCIUM 277 242 11 12
HYDROCHLOROTHIAZIDE 241 238 12 16
METOPROLOL SUCCINATE 224 219 13 11
GABAPENTIN 210 160 14 14
METFORMIN HCL 209 196 15 13
ZOLPIDEM TARTRATE 166 119 16 22
ALLOPURINOL 152 137 17 23
TAMSULOSIN HCL 147 123 18 27
METOPROLOL TARTRATE 144 125 19 10
POTASSIUM CHLORIDE 136 118 20 9
PANTOPRAZOLE SODIUM 134 106 21 31
CITALOPRAM HBR 113 100 22 20
PRAVASTATIN SODIUM 112 99 23 19
CRESTOR 104 88 24 26
CARVEDILOL 102 85 25 24
SERTRALINE HCL 100 94 26 25
GLIPIZIDE 99 95 27 62
GEMFIBROZIL 99 87 27 110
LABETALOL HCL 93 86 29 194
NOVOLOG 92 75 30 107
TRAMADOL HCL 91 89 31 15
TRAZODONE HCL 86 61 32 50
FLUOXETINE HCL 81 55 33 78
ALENDRONATE SODIUM 80 75 34 21
LOSARTAN-HYDROCHLOROTHIAZIDE 80 80 34 49
NEXIUM 78 75 36 40
POLYETHYLENE GLYCOL 3350 76 70 37 41
GLIMEPIRIDE 74 73 38 35
TRICOR 72 58 39 93
ACTOS 72 64 39 115
OXYCODONE HCL 72 59 S2 39 112
FENOFIBRATE 69 69 42 61
FINASTERIDE 69 69 42 94
OXYCONTIN 67 37 S2 44 151
MELOXICAM 65 65 45 30
VENLAFAXINE HCL ER 63 52 46 84
CIPROFLOXACIN HCL 62 62 47 55
LANTUS 62 51 47 46
AMITRIPTYLINE HCL 61 61 R 49 69
DONEPEZIL HCL 59 59 50 28
FLUTICASONE PROPIONATE 59 39 50 39
AZITHROMYCIN 58 49 52 56
DIGOXIN 57 47 53 43
PREDNISONE 55 46 54 29
CARBIDOPA-LEVODOPA 54 41 55 71
AGGRENOX 53 40 56 164
PAROXETINE HCL 52 41 57 65
LOVASTATIN 51 51 58 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.